Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - September 2012

32nd European Peptide Symposium

02 Sep 2012 - 07 Sep 2012 - Athens, Greece

Bookmark and Share

The Symposium will take place at the Megaron Conference Center located in one of the nicest districts of Athens. Around 90 contributions have been selected for oral presentation, and the program will be announced by the end of June.

The Local Organizing Committee promises to offer the famous Greek hospitality to all participants. The social events will be announced later on. Visit Athens and enjoy science, social events, unique archeological sites, walks around Acropolis and the wonderful Greek weather.

Welcome address:

On behalf of the Organising Committee, we have the pleasure of inviting you to the 32nd European Peptide Symposium (32EPS 2012), which will be held in Athens from the 2nd to 7th September, 2012.

The symposium will present the most recent, cutting-edge research on a broad range of topics in the area of Peptide Science by leading international experts from both industry and academia. The scientific program will be structured around international invited speakers and oral presentations of selected high-quality submitted abstracts as well as poster sessions where all delegates are encouraged to present their data.

Athens, a bustling city of 5-million residents, is full of contrasts and pleasant surprises. The history of Athens is one of the longest of any city in Europe and in the world. Three thousand years old cultural riches are housed in approximately 50 national and private museums, including the new Acropolis museum, featuring from neolithic settlement finds to examples of modern art. When you are in Athens you will probably get the impression the city never sleeps.

It is our intention to establish an inspiring atmosphere for fruitful scientific discussions and for initiating new collaborations within and outside Europe.

We are looking forward to welcoming you in Athens at the 32nd European Peptide Symposium.

Prof. George Kokotos

Further information
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos